Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

drug development Press Releases

  + XML/RSS  



By Cambridge Healthtech Institute
A conference dedicated to new antibacterial drugs development, both biologics and small molecule, as well as to the market access and pricing for new antibacterial agents.

By Cambridge Healthtech Institute
Drug Discovery Teams to Unite for 3 Days of Learning & Collaboration - Free Passes Provide Access to Keynote Presentations by Chas Bountra, Martin Tolar, Andrew Hopkins and an Expansive Exhibit Hall

By Cambridge Healthtech Institute
Dr. Wells of the University of Pittsburgh will discuss "An All-Human Microphysiologic Liver System for Carcinoma Metastasis" at this conference - part of the 2nd annual FAST: Functional Analysis & Screening Technologies Congress.

By DelveInsight
Over the past six months, DelveInsight has proven its value to their customers with its excellent deliverables. Now newly launched DelveInsight's Pipeline Reports is the answer to all looking for top notch drug development information.

By InvitroCue Pte Ltd
InvitroCue and HD Biosciences Enter Collaboration Agreement for the Validation of Image Analysis Tools for Preclinical Drug Discovery

By SMi Group Ltd
SMi Reports: Britain was looking to accelerate access to drugs for patients with rare diseases when it launched the Early Access to Medicines Initiative in March this year. This initiative will be extremely beneficial for patients.

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.

By Crown Bioscience
HuTrialTM demonstrates commitment to furthering preclinical understanding in order to improve personal care and increase patient recovery rates

By SMi Group Ltd
Returning for its fitfth year and following on from the major success of previous events, SMI are proud to present the 5th annual Biosimilars & Biobetters Conference, 29th-30th September, 2014, London.

By Online Compliance Panel LLC
Know the complete details, key strategies, regulatory considerations, and marketing strategies for developing 505(b)(2) products

By Calvert Holdings, Inc.
Calvert Holdings, Inc. announced that Michael A. Recny, Ph.D., has been appointed Chief Executive Officer and has been elected a Director of the Company.

By Cambridge Healthtech Institute
Moderated by Freeslate, Inc., Mercer University, Johnson & Johnson, and the University of Miami Miller School of Medicine

By Calvert Holdings, Inc.
Calvert Research, LLC, a business unit of Calvert Holdings, Inc., announced that the U.S.

By Quotient Clinical
Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum.

By KDM Communications
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.

By Cayman Chemical Company
Cayman Chemical announces a partnership with ΔTm Technologies LLC, to develop a series of macromolecular analysis kits that provide a rapid, sensitive, and economical method for assessing both protein stability and protein-ligand interactions using...

By Calvert Holdings, Inc.
Scott Township, PA – June 10, 2013 – Calvert Labs and EyeCRO, two leading providers in early-stage ocular drug research and development, announced today that they have entered into a strategic partnership to expedite preclinical drug development...

By Rosa & Co
PhysioPD™ modeling collaboration in psoriasis to be presented May 20-22, 2013.

By Rosa & Co
Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013.

By Veristat
Collaboration offers clients more streamlined and efficient approach to trial planning

All Press Releases

By SMi Group Ltd
SMi is proud to have Dr. Günter Harms, Market Access & Public Affairs Director at Shire, giving the opening address at this year’s Orphan Drugs and Rare Diseases conference taking place in London on October 20th and 21st 2014.

By Cambridge Healthtech Institute
A conference dedicated to new antibacterial drugs development, both biologics and small molecule, as well as to the market access and pricing for new antibacterial agents.

By Cambridge Healthtech Institute
Drug Discovery Teams to Unite for 3 Days of Learning & Collaboration - Free Passes Provide Access to Keynote Presentations by Chas Bountra, Martin Tolar, Andrew Hopkins and an Expansive Exhibit Hall

By Cambridge Healthtech Institute
Dr. Wells of the University of Pittsburgh will discuss "An All-Human Microphysiologic Liver System for Carcinoma Metastasis" at this conference - part of the 2nd annual FAST: Functional Analysis & Screening Technologies Congress.

By SMi Group Ltd
SMi Group reports (2014.08.22, London): In preparation for the 5th annual Biosimilars and Biobetters Conference, SMi Group has conducted a series of interviews with leading industry experts

By DelveInsight
Over the past six months, DelveInsight has proven its value to their customers with its excellent deliverables. Now newly launched DelveInsight's Pipeline Reports is the answer to all looking for top notch drug development information.

By InvitroCue Pte Ltd
InvitroCue and HD Biosciences Enter Collaboration Agreement for the Validation of Image Analysis Tools for Preclinical Drug Discovery

By SMi Group Ltd
SMi Reports: Britain was looking to accelerate access to drugs for patients with rare diseases when it launched the Early Access to Medicines Initiative in March this year. This initiative will be extremely beneficial for patients.

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.

By Crown Bioscience
HuTrialTM demonstrates commitment to furthering preclinical understanding in order to improve personal care and increase patient recovery rates

By SMi Group Ltd
Returning for its fitfth year and following on from the major success of previous events, SMI are proud to present the 5th annual Biosimilars & Biobetters Conference, 29th-30th September, 2014, London.

By Online Compliance Panel LLC
Know the complete details, key strategies, regulatory considerations, and marketing strategies for developing 505(b)(2) products

By Calvert Holdings, Inc.
Calvert Holdings, Inc. announced that Michael A. Recny, Ph.D., has been appointed Chief Executive Officer and has been elected a Director of the Company.

By Cambridge Healthtech Institute
Moderated by Freeslate, Inc., Mercer University, Johnson & Johnson, and the University of Miami Miller School of Medicine

By Calvert Holdings, Inc.
Calvert Research, LLC, a business unit of Calvert Holdings, Inc., announced that the U.S.

By SMi Group
"Adaptive clinical trials might be globally embraced if the current preoccupation with fixed trial designs was viewed as an “engineering problem” requiring a lot of talk and teamwork between adaptive design experts", said Michael Krams, MD, vice...

By Quotient Clinical
Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum.

By KDM Communications
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.

By Calvert Holdings, Inc.
Calvert Research and Oncoceutics announced today an investment partnership to support the completion of preclinical development for ONC201, Oncoceutics' preclinical stage experimental anti-cancer compound.

By Cayman Chemical Company
Cayman Chemical announces a partnership with ΔTm Technologies LLC, to develop a series of macromolecular analysis kits that provide a rapid, sensitive, and economical method for assessing both protein stability and protein-ligand interactions using...

By Calvert Holdings, Inc.
Scott Township, PA – June 10, 2013 – Calvert Labs and EyeCRO, two leading providers in early-stage ocular drug research and development, announced today that they have entered into a strategic partnership to expedite preclinical drug development...

By Rosa & Co
PhysioPD™ modeling collaboration in psoriasis to be presented May 20-22, 2013.

By Rosa & Co
Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013.

By Mary Ann Liebert, Inc., publishers
New Rochelle, May 16, 2013–Lethal and rescuer genes are defined as genes that when inactivated result in cell death or enhanced cell growth, respectively.

By Veristat
Collaboration offers clients more streamlined and efficient approach to trial planning

By Mary Ann Liebert, Inc., publishers
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside.

By SMi Group Ltd
Adaptive Designs in Clinical Trials to take place in London, UK, 8th & 9th April...

By Cambridge Healthtech Institute
Mar. 20, 2013 - Needham, MA - Part of Cambridge Healthtech Institute’s Bio-IT World Expo, attendees will gain first-hand insight from three plenary keynote presentations, aligned with the event theme of new trends in data generation, knowledge...

By Cures Within Reach
Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and...

By Calvert Holdings, Inc.
Scott Township, PA – Calvert Laboratories and Particle Sciences, two leading companies in their respective fields of preclinical toxicology and drug product formulation, announced today that they have joined forces to offer a streamlined solution to...

By cardiabase
CardiaBase, a global provider of centralized diagnostic services to clinical trials, is pleased to announce that Dr. Pierre Maison-Blanche joined the company as Chief Medical Officer.

By Cambridge Healthtech Institute
Plenary Keynote Panels on "Personalized Oncology: Fulfilling the Promise for Today’s Patients" and "Emerging Technologies & Industry Perspectives" to be Delivered Next Month in San Francisco

By SMi Group
Imaging in Cancer Drug Development taking place in London, March 2013, focuses on current developments surrounding oncology imaging and overcoming chemical challenges in radiotracer development.

By Cambridge Healthtech Institute
Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference

By Cambridge Healthtech Institute
Cambridge Healthtech Institute's Patient-Derived Cancer Tissue Xenograft Models Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.

By Adaptive Clinical Systems
ACRIM, a leading imaging Contract Research Organization (iCRO), has selected Adaptive Clinical Systems’ Cloud-based e-Clinical solution for its EDC needs.

By Biotech Support Group LLC
Cholesterol removal from serum samples using Cleanascite™ for immunogenicity and safety endpoint analysis of pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine.

By Cambridge Healthtech Institute
International Experts in Computational Drug Design, Genome Interpretation, and an All-Star CIO Panel Headline 2013 Bio-IT Conference in Boston

By SMi Group
EU regulations on paediatric drug development are becoming more and more complicated and pharmaceutical companies have to prepare more robust and detailed paediatric investigation plans to ensure the success of their clinical trials

By PATH OneWorld Health
PATH's Drug Development program has developed a new medication to treat diarrhea. This new drug treats the diarrheal process to shorten its duration.

By Rosa & Co
Dr. Lo will present the Webinar “Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to therapy” on November 14, 2012.

By Rosa & Co
Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process at 4th World PK/PD Summit on November 28, 2012 in Frankfort, Germany

By Cambridge Healthtech Institute
Find Strategies to Maximize microRNA as a Target and Tool for Therapeutic Development

By Arrowhead Publishers and Conferences
The 2nd Annual Drug Repositioning and Indications Discovery Conference is being held on October 23-24, 2012 in San Francisco, CA. This conference will feature a variety of speakers from academia, industry, non-profits and government.

By kdm communications
Deal marks Avacta’s entry to the third largest Asia-Pacific biotech market

By World Trade Group
We’re pleased to announce that Andreas Schneider, Vice President Life Science Alliances, Roche, will be speaking at the Early Drug Development Summit, 3rd - 4th December 2012 at the Hotel Palace Berlin, Germany.

By Cambridge Healthtech Institute
Aptiv Solutions, Berry Consultants and Tessella announce a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess the potential for transforming drug development.

By Rosa & Co
Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012

By Mary Ann Liebert, Inc., publishers
The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds.

By ICRC-Weyer GmbH
Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation.



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share